StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 02/25/2013 -- StockRunway.com issues special report on Hot Market Movers – Advanced Cell Technology, Inc. (OTC:ACTC), VELATEL GLOBAL COMM (PINK:VELA), Paradigm Oil and Gas Inc (NDA) (PINK:PDGO) and AMARANTUS BIOSCI INC (OTC:AMBS).
Advanced Cell Technology, Inc. (OTC:ACTC) ended lower by -0.0030 points or -4.05% to complete the day at 0.0710. The total number of shares changed hands during the day was 7.74 million. After opening at $0.07, the stock hit as high as $0.07. However, it traded between $0.05 and$0.12 over the last twelve months.
Why Should Investors Buy ACTC After the Recent Fall? Just Go Here and Find Out
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic, induced pluripotency, and adult stem cell technology in the field of regenerative medicine.
VELATEL GLOBAL COMM (PINK:VELA) closed yesterday at $0.0375, a +7.14% increase. Around 6.51 million shares were traded, beating an-average trading volume of 1.76 million shares. The company is now valued at around $5.08 million.
For How Long VELA will fight for Profitability? Read This Trend Analysis report
VelaTel Global Communications, Inc., through its subsidiaries, operates as a telecommunications carrier primarily in the People’s Republic of China and Peru. It focuses on the deployment of telecommunications networks that utilize wireless broadband access (WBA) in international markets using 2.5 GHz or 3.5 GHz radio frequency spectrum.
Paradigm Oil and Gas Inc (NDA) (PINK:PDGO) moved -7.14 per cent lower at $0.0130 and traded between $0.01 and $0.02 after opening the day at $0.02. Its performance over the last five days remained +116.67%, which stands at +160% for a month. Going back further than one month, 1-year performance after recent close was +23.81%.
Will PDGO Get Buyers Even After The Recent Rally? Find Out Here
Paradigm Oil and Gas, Inc., an exploration stage company, engages in the acquisition, exploration, development, and operation of oil and gas properties. It focuses on exploring oil and gas in the Wichita and Navarro counties. The company is based in Eustace, Texas.
AMARANTUS BIOSCI INC (OTC:AMBS)’s shares rose, gaining +10.94 per cent to close at $0.0710. The stock is down around -46.21% this year and -39.57% for the last 12 months. Around 5.37 million shares changed hands yesterday, higher from an-average trading volume of 11.36 million shares.
For How Long AMBS’s Gloss will Attract Investors? Find out via this report
Amarantus BioScience, Inc., a development-stage biotechnology company, focuses on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI), and other human diseases in the United States.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)